SCHEMBL25840753

SCHEMBL25840753

CSC(=O)CNC(=O)c1cccc(NC(=N)N)c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 5/20 0.44
MEN1 O00255 4/20 0.44
PLK4 O00444 1/20 0.43
CHEK1 O14757 1/20 0.43
AURKA O14965 1/20 0.43
CHUK O15111 1/20 0.43
DAPK3 O43293 1/20 0.43
JAK2 O60674 1/20 0.43
ROCK2 O75116 1/20 0.43
PAK4 O96013 1/20 0.43
CHEK2 O96017 1/20 0.43
CDK1 P06493 1/20 0.43
PIM1 P11309 1/20 0.43
PRKACA P17612 1/20 0.43
FGFR3 P22607 1/20 0.43
RPS6KB1 P23443 1/20 0.43
CDK2 P24941 1/20 0.43
MARK3 P27448 1/20 0.43
AKT1 P31749 1/20 0.43
AKT2 P31751 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7372871 0.87 PLK4 (0.50) KMT2AMEN1PLK4CHEK1AURKA
SCHEMBL26033646 0.85 PLK4 (0.49) KMT2AMEN1PLK4CHEK1AURKA
SCHEMBL7343748 0.85 MEN1 (0.46) KMT2AMEN1PLK4CHEK1AURKA
SCHEMBL7343738 0.84 PLK4 (0.47) KMT2AMEN1PLK4CHEK1AURKA
SCHEMBL6366986 0.84 PLA2G10 (0.47) KMT2AMEN1PLK4CHEK1AURKA
Hydrochloric Acid SCHEMBL6368863 0.83 PLA2G10 (0.46) KMT2AMEN1PLK4CHEK1AURKA
Hydrochloric Acid SCHEMBL6773326 0.83 PLA2G10 (0.46) KMT2AMEN1PLK4CHEK1AURKA
SCHEMBL19426798 0.82 PLK4 (0.48) KMT2AMEN1PLK4CHEK1AURKA
SCHEMBL7339143 0.82 RXFP1 (0.48) KMT2AMEN1PLK4CHEK1AURKA
SCHEMBL26049628 0.82 NPSR1 (0.46) KMT2AMEN1PLK4CHEK1AURKA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230226193-A1 LIPID CONJUGATES FOR THE DELIVERY OF THERAPEUTIC AGENTS Arrowhead Pharmaceuticals, Inc. 2023-07-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230226193-A1 LIPID CONJUGATES FOR THE DELIVERY OF THERAPEUTIC AGENTS CPT1B, MUSK, MYLK2 KMT2A 1603/4885MEN1 4753/4885PLK4 530/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.